1000 participants enrolled in TB trial
Some 1 000 participants are enrolled in a Phase 3 clinical trial being run by Africa Health Research Institute (AHRI) in Mtubatuba
The tuberculosis (TB) epidemic continues to impact South Africa, but there is hope in the form of the M72 TB vaccination.
In the last seven years, South Africa has recorded a 50% reduction in TB incidence, yet it still has the highest rates globally, with 54 000 people dying from the disease annually.
Currently, some 1 000 participants are enrolled in a Phase 3 clinical trial being run by the Africa Health Research Institute (AHRI) in Mtubatuba…
Read the full story in the ZO Monday edition, out on the shelves and on the ZO app.
Click on the image below to download the ZO app to your android device from the Google Play Store and for your Apple device from the Apple App Store!
HAVE YOUR SAY
Like our Facebook page and follow us on Twitter.
For news straight to your phone invite us:
WhatsApp – 060 784 2695
Instagram – zululand_observer
